A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

Summary

This is a randomized, observer-blinded, Aqueous Gel-controlled trial examining the safety and efficacy of daily application of DBI-001 Gel vs. DBI-002 Gel vs. Aqueous Gel for 24 consecutive weeks in subjects with onychomycosis.

Timeline

Start

2023-11

Primary completion

2023-11-30

Completion

2023-11-30

Outcome

Outcome not reported

Stopped: “Suspended: Study halted prematurely but potentially will resume. Sponsor suspension, and not due to safety or site-related matters.”

Drugs

Indications